Published Sep 30, 2024
Liran Belenzon from BenchSci
Liran Belenzon, Co-Founder and CEO of BenchSci, delves into revolutionizing drug discovery with AI, sharing the startup's journey, commercialization strategies, scaling challenges, and effective fundraising approaches.

Topics covered
Popular Clips
Questions from this episode
- Asked by 96 people
- Asked by 61 people
- Asked by 58 people
- Asked by 41 people
- Asked by 16 people
Episode Highlights
Related Episodes


Lars Leckie from Aspenwood Ventures
Answers 383 questions

Brendan Baker from Rackhouse Venture Capital
Answers 383 questions

Christian Levan
Answers 383 questions

Sam Ifergan from iGan Partners
Answers 383 questions

Dan Belostotsky from HonestDoor
Answers 383 questions

Alanna Lopes Souza from Drive Capital
Answers 383 questions

Solon Angel, Founder, Investor and Advisor.
Answers 383 questions

Bertrand Nembot from Billdr
Answers 383 questions

David Hariri from Ada
Answers 383 questions

Vedant Suri from General Catalyst
Answers 383 questions

Alex Barrett from Meroka
Answers 383 questions

Antoine Nivard from Blank Ventures
Answers 383 questions
Jodi Krakower Kessler from 3L Capital
Answers 383 questions

Jonathan Shaanan from Circle K Ventures
Answers 383 questions

Ben Rollert from Composer
Answers 383 questions
